Biovail Corp. is in the Pharma Industry

• Sort by

• Biovail and Teva Announce Resolution of Arbitration Proceedings; Expansion of Relationship

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) and Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the pending arbitration between the two companies relating to a dispute over their existing agreement has been amicably resolved in its entirety, with each side granting a full release to the other in respect of...

  Research articles 2004-10-01

  Tags: arbitration, Biovail Corp.

• Teva and Biovail Announce Resolution of Arbitration Proceedings; Expansion of Relationship

  JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Biovail Corporation (NYSE:BVF) (TSX:BVF) announced today that the pending arbitration between the two companies relating to a dispute over their existing agreement has been amicably resolved in its entirety, with each side granting a full release to the other in respect...

  Research articles 2004-10-01

  Tags: agreement, arbitration, Biovail Corp.

• Biovail and Teva Announce Resolution of Arbitration Proceedings; Expansion of Relationship.

  TORONTO, Oct 1, 2004 CCNMatthews via COMTEX TORONTO, Oct 1, 2004 CCNMatthews via COMTEX

  Research articles 2004-10-01

  Tags: arbitration, Biovail Corp.

Additional Resources

• Biovail to Participate at Upcoming Conferences

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will participate at the 2008 Annual Credit Suisse Health Care Conference at the Arizona Biltmore Resort in Phoenix, Arizona and at the Lazard Capital Markets 5th Annual Healthcare Conference at the St. Regis Hotel in New York City. ...

  Articles 2008-11-11

• Biovail Reports Third-Quarter 2008 Financial Results

  Third-Quarter 2008 Revenues of $181.1 Million; Third-Quarter 2008 Net Income of $48.4 Million; U.S. GAAP EPS of $0.31; Acquires First Specialty Central Nervous System Product for Launch in 2008; Files ANDA for Fenofibrate Tablets; Strengthened Management Team with Chief Scientific Officer ...

  Articles 2008-11-06

• Biovail Declares Quarterly Dividend

  Total Dividends Declared Since December 2005 of $4.50 per share TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.375 per share payable on January 5, 2009, to shareholders of record at the close of business December...

  Articles 2008-11-06

• Biovail Appoints Dr. H. Christian Fibiger Senior Vice-President, Chief Scientific Officer

  TORONTO -- Biovail Corporation (NYSE, TSX: BVF) today announced the appointment of Dr. H. Christian Fibiger as Senior Vice-President, Chief Scientific Officer of Biovail Laboratories International SRL BLS, the Company's principal operating subsidiary. The appointment is effective November 24, 2008. Dr. Fibiger brings a wealth of academic and...

  Articles 2008-11-06

• Biovail Announces Third-Quarter 2008 Earnings Release, Conference-Call Details

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that it will host a conference call and Webcast on Thursday, November 6, 2008, at 8:30 a.m. EST, for Company executives to discuss third-quarter 2008 financial and operational results. Following the discussion, Biovail executives will address inquiries from investment analysts....

  Articles 2008-10-28

• Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Biovail Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the December 8, 2008 Lead Plaintiff Deadline

  Brower Piven, A Professional Corporationannounces that a class action lawsuit has been commenced in the UnitedStates District Court for the Southern District of New York on behalf ofpurchasers of the securities of Biovail Corporation ("Biovail" or the"Company") (NYSE: BVF) during the period between December 14, 2006 and July19, 2007, inclusive...

  Articles 2008-10-15

• Wall Street Media Presents an Exclusive Video from Natixis Bleichroeder 2nd Annual Hidden Gems Conference

  NEW YORK -- Wall Street Media presents an exclusive video of Mr. Joseph J. Corasanti, CEO of CONMED Corporation, (NASDAQ: CNMD) discussing their electro surgery products, and branching out into orthopedics. Please visit the following link to view the video: http://www.wsmco.com/show.aspx?1130_Up_and_Coming_Stocks Wall Street Media...

  Articles 2008-10-13

• INVESTOR ALERT: KGS Notifies Biovail Corporation Purchasers With Losses Greater Than $300,000, of Lead Plaintiff Application Deadline in Securities Class Action Lawsuit -- BVF

  Kahn Gauthier Swick, LLC ("KGS") announcesthat a securities class action lawsuit was filed in the United StatesDistrict Court for the Southern District of New York, on behalf ofpurchasers of the securities and common stock of Biovail Corporation("Biovail") (NYSE: BVF) during the period between December 14, 2006 andJuly 19, 2007, inclusive...

  Articles 2008-10-11

• Biovail Comments on Filing of Lawsuit

  TORONTO -- Biovail Corporation (NYSE, TSX: BVF) today announced that it has been notified that a proposed securities class action lawsuit has been filed in the U.S. District Court Southern District of New York against the Company, its Chairman and two former officers. The complaint has been filed on behalf...

  Articles 2008-10-09

• Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Biovail Corporation

  SAN DIEGO -- Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") (http://www.csgrr.com/cases/biovailcorp/) today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Southern District of New York on behalf of purchasers of Biovail Corporation ("Biovail") (NYSE:BVF)...

  Articles 2008-10-09

• Izard Nobel LLP Announces Class Action Lawsuit against Biovail Corporation

  HARTFORD, Conn. -- The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Southern District of New York on behalf of those...

  Articles 2008-10-09

• Biovail to Present at Natixis Bleichroeder Hidden Gems Conference

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the Natixis Bleichroeder 2nd Annual Hidden Gems Conference at The Waldorf=Astoria hotel in New York City. Biovail's presentation is scheduled for Monday, October 13, 2008 at 2 p.m. EDT. A live and archived Webcast...

  Articles 2008-10-07

• Biovail to Participate at Upcoming Investor Conferences

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company will present at the at the CIBC World Markets 7th Annual Eastern Institutional Conference at Le Centre Sheraton Hotel in Montreal, Quebec and the UBS 2008 Global Life Sciences Conference at the Grand Hyatt New York Hotel in New York...

  Articles 2008-09-18

• Biovail Receives Canadian Approval for Ralivia™ for the Treatment of Moderately Severe Pain

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that it has received an expanded indication for once-daily Ralivia[TM] - to include the treatment of moderately severe pain in addition to moderate pain - from the Therapeutic Products Directorate TPD in Canada. Ralivia[TM] is now indicated for the management of moderate to...

  Articles 2008-08-25

• Biovail Appoints Peggy Mulligan Chief Financial Officer

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced the appointment of Peggy Mulligan, FCA as Chief Financial Officer, effective September 3, 2008. Mrs. Mulligan succeeds Adrian A. De Saldanha, who had been serving as Biovail's Interim Chief Financial Officer. Mrs. Mulligan was most recently a Principal at Priiva Consulting Corporation,...

  Articles 2008-08-21

• Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced the appointment of Dr. Neil M. Sussman as Vice-President, Neurologic and Psychiatric Development of Biovail Technologies, Ltd. The appointment is effective immediately. Dr. Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous...

  Articles 2008-08-20

• Commentary: Destroyed e-evidence results in sanctions

  Last year, amendments to the Federal Rules of Civil Procedure relating to electronically-stored information ESI provoked much discussion about what was required with respect to preserving and producing ESI. Developing case law is providing some real-life lessons about what is, and what is not, acceptable in...

  Articles 2008-08-07